SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,781.76 -120.83
( -0.16%)

Global Indices

Nasdaq

52,089.49 -312.17
(-0.60%)

Dow Jones

7,612.71 -44.65
(-0.58%)

Hang Seng

63,979.83 -1,291.12
(-1.98%)

Nikkei 225

10,611.90 -58.16
(-0.55%)

Forex

USD-INR

95.06 0.32
(0.34%)

EUR-INR

110.60 0.49
(0.45%)

GBP-INR

128.80 0.53
(0.41%)

JPY-INR

0.62 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hikal Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524735

INE475B01022

97.2386745

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HIKAL

67.9

2896.95

EPS(TTM)

Face Value()

Div & Yield %

3.46

0.26

Back

l&smill green ltd

Dr Reddy's Laboratories consolidated net profit declines 68.67% in the June 2026 quarter

Jul 22,2026

Net profit of Dr Reddy's Laboratories declined 68.67% to Rs 444.30 crore in the quarter ended June 2026 as against Rs 1418.10 crore during the previous quarter ended June 2025. Sales declined 5.56% to Rs 8070.50 crore in the quarter ended June 2026 as against Rs 8545.20 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	8070.50	8545.20	-6
OPM %	10.65	25.44	-
PBDT	1089.90	2381.10	-54
PBT	553.30	1905.00	-71
NP	444.30	1418.10	-69

74,781.76 -120.83 ( -0.16%)

52,089.49 -312.17 (-0.60%)

7,612.71 -44.65 (-0.58%)

63,979.83 -1,291.12 (-1.98%)

10,611.90 -58.16 (-0.55%)

95.06 0.32 (0.34%)

110.60 0.49 (0.45%)

128.80 0.53 (0.41%)

0.62 0.00 (0.59%)